Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab in Early Acute Sepsis
NCT03869073Phase 2Unknown
- Sponsor
- University of British Columbia
- Start
- Feb 2019
- Primary completion
- Feb 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of evolocumab in sepsis, sponsored by University of British Columbia. Status: unknown.
02
Drugs
evolocumab
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT03869073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03869073.